UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book Journal article
Chen, Fuduan, Zhong, Hao, Chan, Ging, Ouyang, Defang. A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book[J]. AAPS PharmSciTech, 2024, 25(5), 88.
Authors:  Chen, Fuduan;  Zhong, Hao;  Chan, Ging;  Ouyang, Defang
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/3.5 | Submit date:2024/05/16
Biologics  Biopharmaceutical Landscape  Dosage Form  Excipient  Purple Book  
The study of different markers among Chuanxiong Chatiao dosage forms based on bioactive components and antiplatelet aggregation biopotency integrated with chemometrics Journal article
Xiao, Jia jia, Weng, Yu ping, Luo, Long biao, Wang, Jing qi, Lin, Huan zhao, Zhang, Guang mou, Yue, Lin, Yao, Yi xin. The study of different markers among Chuanxiong Chatiao dosage forms based on bioactive components and antiplatelet aggregation biopotency integrated with chemometrics[J]. Arabian Journal of Chemistry, 2024, 17(1), 105421.
Authors:  Xiao, Jia jia;  Weng, Yu ping;  Luo, Long biao;  Wang, Jing qi;  Lin, Huan zhao; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:5.3/5.6 | Submit date:2024/02/22
Antiplatelet Aggregation Biopotency  Bioactive Components  Bioassay  Chuanxiong Chatiao Dosage Forms  Different Markers  Quantification  
Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women Journal article
Song,Yudi, Wang,Wei, Liu,Xinyang, Chen,Jingsi, Chen,Dunjin, Wang,Xiaoyi, Li,Wei, Ouyang,Defang. Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women[J]. Pharmaceutical Research, 2023, 40(7), 1765-1775.
Authors:  Song,Yudi;  Wang,Wei;  Liu,Xinyang;  Chen,Jingsi;  Chen,Dunjin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.5/3.8 | Submit date:2023/08/03
Dosage  Labetalol  Physiologically-based Pharmacokinetics  Pregnancy  
Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms Review article
2022
Authors:  Jiang, Junhuang;  Ma, Xiangyu;  Ouyang, Defang;  Williams, Robert O.
Favorite | TC[WOS]:20 TC[Scopus]:35  IF:4.9/5.5 | Submit date:2022/12/01
Solid Dosage Formulation  Artificial Intelligence  Machine Learning  Deep Learning  
The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations Journal article
Hua Luo, Hongguo Chen, Chang Liu, Siyuan Zhang, Chi Teng Vong, Dechao Tan, Yuntao Dai, Yitao Wang, Shilin Chen. The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations[J]. Chinese Medicine, 2021, 16(1), 70.
Authors:  Hua Luo;  Hongguo Chen;  Chang Liu;  Siyuan Zhang;  Chi Teng Vong; et al.
Favorite | TC[WOS]:15 TC[Scopus]:17  IF:5.3/5.5 | Submit date:2021/12/09
Chinese Classical Formulas  Material Reference  Origin Of The Medicinal Materials  Processing Methods  Dosage Verifcation  Quality Control  Development Strategies  Safety Evaluation  
National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018 Journal article
Shi, Honghao, Chen, Xianwen, Liu, Xueli, Zhu, He, Yu, Fei, Ung, Carolina Oi Lam, Chan, Wai Sin, Hu, Hao, Han, Sheng. National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018[J]. Journal of Pharmaceutical Policy and Practice, 2021, 14(1).
Authors:  Shi, Honghao;  Chen, Xianwen;  Liu, Xueli;  Zhu, He;  Yu, Fei; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:3.3/3.7 | Submit date:2021/12/09
Analgesics  Dosage Utilization  Drug Utilization  Pain Management  Procurement Cost  Public Hospital  
我国中药产品开发趋势:对2011—2015 年CFDA 批准中药的分析 Journal article
Song, Q, Hu, H.. 我国中药产品开发趋势:对2011—2015 年CFDA 批准中药的分析[J]. 中草药, 2017, 1262-1266.
Authors:  Song, Q;  Hu, H.
Favorite |  | Submit date:2022/07/27
Chinese materia medica  China Food and Drug Administration  registration application  registration categories  dosage form  therapeutic area  
Development trend of Chinese materia medica products in China: An analysis of CFDA-approved Chinese materia medica (2011-2015) Journal article
Song Q.-R., Hu H.. Development trend of Chinese materia medica products in China: An analysis of CFDA-approved Chinese materia medica (2011-2015)[J]. Chinese Traditional and Herbal Drugs, 2017, 48(6), 1262-1266.
Authors:  Song Q.-R.;  Hu H.
Favorite | TC[Scopus]:0 | Submit date:2018/12/28
China Food And Drug Administration  Chinese Materia Medica  Dosage Form  Registration Application  Registration Categories  Therapeutic Area  
Development trend of Chinese materia medica products in China: An analysis of CFDA-approved Chinese materia medica (2011-2015) Journal article
Song,Qi Rui, Hu,Hao. Development trend of Chinese materia medica products in China: An analysis of CFDA-approved Chinese materia medica (2011-2015)[J]. Chinese Traditional and Herbal Drugs, 2017, 48(6), 1262-1266.
Authors:  Song,Qi Rui;  Hu,Hao
Favorite | TC[Scopus]:0 | Submit date:2021/03/01
China Food And Drug Administration  Chinese Materia Medica  Dosage Form  Registration Application  Registration Categories  Therapeutic Area  
Interaction between superplasticizer and cement by electrical resistivity method Journal article
Zeng X., Sui T., Xie Y., Li Z., Fan L.. Interaction between superplasticizer and cement by electrical resistivity method[J]. Kuei Suan Jen Hsueh Pao/ Journal of the Chinese Ceramic Society, 2008, 36(10), 1390-1395.
Authors:  Zeng X.;  Sui T.;  Xie Y.;  Li Z.;  Fan L.
Favorite |  | Submit date:2019/04/08
Adsorption  Dissolution  Fluidity  Initial resistivity  Optimal dosage  Superplasticizer